Skip to content

Safety and Feasibility of Arrhythmia Ablation Using the Amigo Remote Robotic System as Compared With Manual Ablation

Safety and Feasibility of Arrhythmia Ablation Using the Amigo Remote Robotic System as Compared With Manual Ablation

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01834872
Enrollment
50
Registered
2013-04-18
Start date
2012-09-30
Completion date
2014-03-31
Last updated
2013-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrhythmias

Brief summary

The aim of this prospective observational study is to evaluate the performance of Amigo RCS in ablation procedures for most common arrhythmias as compared to a conventional manual approach.

Interventions

DEVICEAmigo
DEVICEManual ablation

Sponsors

Catheter Robotics, Inc.
CollaboratorINDUSTRY
Instituto de Investigación Sanitaria Gregorio Marañón
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients referred to our electrophysiology laboratory to treat any type of arrhythmia with catheter ablation

Exclusion criteria

* NA

Design outcomes

Primary

MeasureTime frameDescription
Ablation Success1 yearGlobal efficacy: Recurrence rate Re-do procedures Proportion of patients under anti arrhythmic treatment
Safety Endpoint1 YearAny complications that could be attributed to the procedure during follow-up.

Secondary

MeasureTime frameDescription
Acute Ablation SuccessDuring ProcedureAccessory pathway: Anterograde and retrograde conduction block through the accessory Pathway Atrial fibrillation: % patients with all PV disconnected circumferential ablation with electrical disconnection of all pulmonary veins Common-type atrial flutter: Bidirectional cavotricuspid isthmus block AVNRT/Ventricular tachycardia/other atrial arrhythmias: Arrhythmia termination / absence o induction
Acute Safety EndpointDuring ProcedureProcedure complications: Any complication during the electrophysiological procedure and 1 week post ablation that could be attributed to the procedure: Vascular complication, pericardial effusion/cardiac tamponade, heart failure, others. The number of adverse events will be collected.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 22, 2026